Skip to main content

FDA panel recommends Pfizer's COVID booster doses for people 65 and older after rejecting third shots for general population

   September 17, 2021

An influential FDA advisory committee on Friday rejected a proposal to distribute booster shots of Pfizer's and BioNTech’s COVID-19 vaccine to the general public, paring back those plans to unanimously recommend the third shots to people age 65 and older and other vulnerable Americans.

Full story

Get the latest on healthcare leadership in your inbox.